The company's shares (LLY) climbed 2.3% Tuesday to end at $988.62 a share, after closing at a record high of $966.64 on Monday. The rally has pushed Lilly's market capitalization up to $934.6 billion, ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

The company's shares (LLY) climbed 2.5% in afternoon trading on Tuesday, after closing at a record high of $966.64 on Monday. That rally pushed Lilly's market capitalization up to $937 billion, ...

Novo Nordisk has cut prices of its weight-loss drug Wegovy by up to 37% in India. This move intensifies competition with Eli ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

Eli Lilly and Novo Nordisk agreed to discount their GLP-1 medications from $1350 per month to around $245 to $350 per month.

There’s a reason why millions of people in the UK are on weight-loss injections – and it’s not because we’re all weak, writes ...

Novo Nordisk cuts Wegovy prices in India by up to 33% to boost access and counter Mounjaro’s growing market lead.

Danish drugmaker Novo Nordisk has cut the price of its weight-loss drug Wegovy by up to 33% in India, a key battleground for ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...

David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...